Actively Recruiting

Phase 4
Age: 0Months - 5Months
MALE
NCT07508124

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

Led by Baylor College of Medicine · Updated on 2026-04-02

40

Participants Needed

3

Research Sites

87 weeks

Total Duration

On this page

Sponsors

B

Baylor College of Medicine

Lead Sponsor

S

Seattle Children's Hospital

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this smaller clinical trial is to evaluate the study design of this research to help prepare for a larger research study in the future. The future larger study would focus on whether steroid cream can reduce recurrent urinary tract infections in male infants, who are not circumcised. Male infants, who are enrolled in this study, would receive either the steroid cream or a placebo cream (a look alike cream without steroids). The cream would be applied twice a week for four weeks. Then there would be two follow up visits with the research team to measure whether the infant experienced any urinary tract infections and to measure parent perceptions of their experience participating in the study.

CONDITIONS

Official Title

Topical Steroids to Prevent Recurrent Urinary Tract Infections in Uncircumcised Male Infants: a Pilot Study

Who Can Participate

Age: 0Months - 5Months
MALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Uncircumcised male infants younger than 6 months old
  • Confirmed first urinary tract infection diagnosed by both physician and laboratory tests
  • Fever of 38.0°C or higher, or low body temperature below 36.0°C during emergency or hospital stay, or reported by parent
Not Eligible

You will not qualify if you...

  • Legal guardian unavailable to provide consent
  • Infant is in Child Protective Services custody
  • Guardian requests urology referral for circumcision
  • Medical need for circumcision due to recurrent balanitis or ballooning of foreskin when urinating
  • Past diagnosis of penile abnormalities such as epispadius, hypospadias, or congenital penile curvature
  • Prior use of topical steroid therapy for phimosis
  • History of allergy to topical steroids
  • Legal guardian not fluent in English or Spanish
  • Foreskin is fully retractable
  • Presence of open wounds on the penis or groin area

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Texas Children's Hospital Main campus

Houston, Texas, United States, 77030

Actively Recruiting

2

Texas Children's Hospital West Campus

Katy, Texas, United States, 77094

Not Yet Recruiting

3

Seattle Children's Hospital

Seattle, Washington, United States, 98105

Not Yet Recruiting

Loading map...

Research Team

S

Sowdhamini Wallace, DO, MS

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here